The DOI matches its Crossref record.
Distinguishing Clinically Important from Unimportant Prostate Cancers Before Treatment: Value of Systematic Biopsies
Abstract
PURPOSE: We assessed the ability of diagnostic tests to distinguish clinically unimportant cancers. MATERIALS AND METHODS: We correlated T stage (based on digital examination and ultrasound), prostate specific antigen (PSA), PSA density and pathological features of cancer in systematic biopsy specimens with features of cancer in 170 radical prostatectomy specimens. Clinically unimportant cancers were defined as small (0.5 cm.3 or less), well or moderately differentiated and confined to the prostate. RESULTS: Of the patients 10% had an unimportant cancer. On logistic regression analysis the 2 significant predictors were maximum length of cancer in any core and PSA density. Of 12 patients with maximum cancer length 2 mm. or less and PSA density less than 0.1., 75% had an unimportant cancer compared to 5% of the remaining 158 (p < 0.0005). CONCLUSIONS: Quantitative analysis of systematic biopsy specimens combined with PSA density provides valuable staging information and helps to identify cancers of low biological potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
Weinreb, J. C., Barentsz, J. O., Choyke, P. L., Cornud, F., Haider, M. A., Macura, K. J., Margolis, D., Schnall, M. D., Shtern, F., Tempany, C. M., et al. (2016) · European Urology · doi:10.1016/j.eururo.2015.08.052 · Cited by 2,951
Drost, F.-J. H., Osses, D. F., Nieboer, D., Steyerberg, E. W., Bangma, C. H., Roobol, M. J., & Schoots, I. G. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012663.pub2 · Cited by 640
Moore, C. M., Kasivisvanathan, V., Eggener, S., Emberton, M., Fütterer, J. J., Gill, I. S., Grubb III, R. L., Hadaschik, B., Klotz, L., Margolis, D. J. A., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.03.030 · Cited by 450
Norberg, M., Egevad, L., Holmberg, L., Sparén, P., Norlén, B. J., & Busch, C. (1997) · Urology · doi:10.1016/s0090-4295(97)00306-3 · Cited by 423
Serial Biopsy Results in Prostate Cancer Screening Study
ROEHL, K. A., ANTENOR, J. A. V., & CATALONA, W. J. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64999-3 · Cited by 362
Metadata
- Authors
- Goto, Y., Ohori, M., Arakawa, A., Kattan, M. W., Wheeler, T. M., & Scardino, P. T.
- Venue
- Journal of Urology
- Published
- 1996-09
- Volume
- 156
- Issue
- 3
- Pages
- 1059-1063
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2150292610
- Cited by
- 197
- References
- 0
- FWCI
- 14.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Distinguishing Clinically Important from Unimportant Prostate Cancers Before Treatment: Value of Systematic Biopsies. https://app.cochat.ai/papers/10.1016/s0022-5347(01)65702-1
- The paper
- Goto, Y., Ohori, M., Arakawa, A., Kattan, M. W., Wheeler, T. M., & Scardino, P. T. (1996). Distinguishing Clinically Important from Unimportant Prostate Cancers Before Treatment: Value of Systematic Biopsies. Journal of Urology. https://doi.org/10.1016/s0022-5347(01)65702-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.